Klaboch J.
- Country
- Czechia
- Department
- Nefrologie - I. interní klinika
Research Overview
Data & Insights
Has run more than one trial at 0 of 26 partner sites.
Specializations
Hematologic Malignancies
The investigator’s work centers on blood cancers and their evolving therapeutic landscapes.
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Acute Myeloid Leukemia
- Mantle Cell Lymphoma
Emphasis is placed on novel combination regimens and disease‑monitoring strategies.
Solid Tumor Oncology
Research activities include major solid tumors across diverse organ systems.
- Breast Cancer
- Urothelial Carcinoma
- Renal Cell Carcinoma
- Non‑Small Cell Lung Cancer
- Gastric and GEJ Adenocarcinoma
Studies evaluate targeted agents, immunotherapies, and precision‑medicine approaches.
Cardio‑Renal and Metabolic Disorders
Interest lies at the intersection of cardiovascular disease and renal health.
- Heart Failure
- Acute Coronary Syndrome
- Atrial Fibrillation
- Chronic Kidney Disease
- Diabetic Macular Edema
Research focuses on agents influencing fluid balance, cardiovascular outcomes, and kidney function.
Immune‑Mediated Inflammatory Diseases
The investigator engages in trials targeting chronic inflammatory conditions.
- Asthma
- Chronic Obstructive Pulmonary Disease
- Psoriasis
- Atopic Dermatitis
- Hidradenitis Suppurativa
Efforts assess biologic therapies and patient‑centred outcome measures.
Transplantation and Graft‑Versus‑Host Disease
Activities include management of complications after hematopoietic stem cell transplantation.
- Graft‑Versus‑Host Disease
- Stem Cell Transplantation
- Primary Myelofibrosis
- Post‑Polycythemia Vera Myelofibrosis
- Post‑Essential Thrombocythemia Myelofibrosis
Focus is on prevention, early detection, and therapeutic modulation of post‑transplant immune responses.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.